• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测和分析肝病患者液体活检中的循环上皮细胞。

Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.

机构信息

Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

出版信息

Gastroenterology. 2018 Dec;155(6):2016-2018.e11. doi: 10.1053/j.gastro.2018.09.020. Epub 2018 Sep 13.

DOI:10.1053/j.gastro.2018.09.020
PMID:30218669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6347478/
Abstract

Epithelial cells in the circulation (circulating epithelial cells, or CECs) are analyzed as a non-invasive method to detect cancers; we investigated whether analysis of hepatocytes in the circulation can identify patients with chronic liver disease or hepatocellular carcinoma (HCC). We previously developed a cell-sorting device to isolate CECs from patient blood samples and combined it with an mRNA analysis system to identify CECs with liver-specific markers. We tested the ability of this device to detect CECs of hepatocyte origin in blood samples from healthy individuals (n=10), patients with chronic liver disease without HCC (n=39), and patients with HCC (n=54), using immunofluorescence. We confirmed hepatocyte origin using RNA-sequencing analysis. We found a similar concentration of circulating hepatocytes in blood samples from patients with chronic liver disease and HCC but an increased concentration from patients with advanced fibrosis compared to those without advanced fibrosis. Circulating hepatocytes isolated from patients with HCC had a different gene expression profile than those from patients with chronic liver disease. This system for detecting and analyzing circulating hepatocytes might be used in the evaluation of benign and malignant liver disease.

摘要

循环中的上皮细胞(循环上皮细胞,或 CECs)被分析为一种非侵入性方法来检测癌症;我们研究了分析循环中的肝细胞是否可以识别慢性肝病或肝细胞癌(HCC)患者。我们之前开发了一种细胞分选装置,从患者的血液样本中分离 CECs,并将其与 mRNA 分析系统相结合,以识别具有肝脏特异性标记的 CECs。我们使用免疫荧光法测试了该装置在来自健康个体(n=10)、无 HCC 的慢性肝病患者(n=39)和 HCC 患者(n=54)的血液样本中检测源自肝细胞的 CECs 的能力。我们使用 RNA 测序分析证实了肝细胞的来源。我们发现慢性肝病和 HCC 患者的血液样本中循环肝细胞的浓度相似,但与无晚期纤维化的患者相比,晚期纤维化患者的浓度增加。从 HCC 患者中分离出的循环肝细胞的基因表达谱与慢性肝病患者不同。这种用于检测和分析循环肝细胞的系统可能用于评估良性和恶性肝病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/6347478/0cdb2457f916/nihms-1506567-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/6347478/0fc3c5182a8a/nihms-1506567-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/6347478/0cdb2457f916/nihms-1506567-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/6347478/0fc3c5182a8a/nihms-1506567-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ff/6347478/0cdb2457f916/nihms-1506567-f0002.jpg

相似文献

1
Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.检测和分析肝病患者液体活检中的循环上皮细胞。
Gastroenterology. 2018 Dec;155(6):2016-2018.e11. doi: 10.1053/j.gastro.2018.09.020. Epub 2018 Sep 13.
2
Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes.
J Hepatol. 1994 Mar;20(3):398-404. doi: 10.1016/s0168-8278(94)80015-4.
3
Liquid biopsies for hepatocellular carcinoma.液体活检在肝细胞癌中的应用。
Transl Res. 2018 Nov;201:84-97. doi: 10.1016/j.trsl.2018.07.001. Epub 2018 Jul 6.
4
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.液体活检在肝细胞癌中作为预后和预测生物标志物的临床应用:循环肿瘤细胞和循环肿瘤 DNA。
J Exp Clin Cancer Res. 2018 Sep 3;37(1):213. doi: 10.1186/s13046-018-0893-1.
5
Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.外周静脉血中循环肝细胞癌细胞的灵敏检测
Cancer. 1995 May 1;75(9):2214-9. doi: 10.1002/1097-0142(19950501)75:9<2214::aid-cncr2820750905>3.0.co;2-x.
6
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.肝细胞癌中的循环肿瘤细胞:病例与对照的检测、计数及二代测序的初步研究
BMC Cancer. 2015 Mar 31;15:206. doi: 10.1186/s12885-015-1195-z.
7
Liquid biopsy for liver diseases.液体活检在肝脏疾病中的应用。
Gut. 2018 Dec;67(12):2204-2212. doi: 10.1136/gutjnl-2017-315846. Epub 2018 Sep 3.
8
[The level of IL-8 in the serum of patients suffering from chronic hepatic diseases and primary hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2002 Dec;10(6):432-3.
9
Circulating microRNAs as biomarkers for hepatocellular carcinoma.循环 microRNAs 作为肝细胞癌的生物标志物。
J Clin Gastroenterol. 2011 Apr;45(4):355-60. doi: 10.1097/MCG.0b013e3181f18ac2.
10
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.液体活检在肝细胞癌中的应用:循环肿瘤细胞和循环肿瘤 DNA。
Mol Cancer. 2019 Jul 3;18(1):114. doi: 10.1186/s12943-019-1043-x.

引用本文的文献

1
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications.循环肿瘤细胞:基于血液的检测、分子生物学及临床应用。
Cancer Cell. 2025 Aug 11;43(8):1399-1422. doi: 10.1016/j.ccell.2025.07.008. Epub 2025 Jul 31.
2
Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications.肝细胞癌中的液体活检:挑战、进展及临床意义
Clin Mol Hepatol. 2025 Feb;31(Suppl):S255-S284. doi: 10.3350/cmh.2024.0541. Epub 2024 Nov 28.
3
Prognostic prediction signature and molecular subtype for liver cancer: A CTC/CTM‑related gene prediction model and independent external validation.肝癌的预后预测特征及分子亚型:一种与循环肿瘤细胞/循环肿瘤微栓相关的基因预测模型及独立外部验证
Oncol Lett. 2024 Sep 3;28(5):531. doi: 10.3892/ol.2024.14664. eCollection 2024 Nov.
4
Assessing the complementary information from an increased number of biologically relevant features in liquid biopsy-derived RNA-Seq data.评估液体活检来源的RNA测序数据中数量增加的生物学相关特征所提供的补充信息。
Heliyon. 2024 Mar 12;10(6):e27360. doi: 10.1016/j.heliyon.2024.e27360. eCollection 2024 Mar 30.
5
Detection of Circulating Tumor Cells by Cell Block Technique in Malignant Tumors.应用细胞块技术检测恶性肿瘤中的循环肿瘤细胞
J Cytol. 2024 Jan-Mar;41(1):41-46. doi: 10.4103/joc.joc_123_23. Epub 2023 Dec 28.
6
Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.液体活检在肝细胞癌中的应用:循环肿瘤细胞在诊断、预后和治疗监测中的意义。
Int J Mol Sci. 2023 Jun 26;24(13):10644. doi: 10.3390/ijms241310644.
7
Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update.肝细胞癌-胆管癌合并症的病理学:最新进展
Cancers (Basel). 2023 Jan 13;15(2):494. doi: 10.3390/cancers15020494.
8
Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.分析头颈部鳞状细胞癌循环肿瘤细胞的上皮-间充质转化状态。
Head Neck. 2022 Nov;44(11):2545-2554. doi: 10.1002/hed.27167. Epub 2022 Aug 5.
9
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?肝细胞癌中的液体活检:我们目前的进展如何?
Cancers (Basel). 2021 May 10;13(9):2274. doi: 10.3390/cancers13092274.
10
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review.当组织成为问题时,液体活检则不成问题:综述。
Oncol Ther. 2021 Jun;9(1):89-110. doi: 10.1007/s40487-021-00144-6. Epub 2021 Mar 10.

本文引用的文献

1
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.一种基于RNA的特征能够实现对肝细胞癌循环肿瘤细胞的高特异性检测。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1123-1128. doi: 10.1073/pnas.1617032114. Epub 2017 Jan 17.
2
Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer.睾丸钙结合蛋白的表达促进结直肠癌的侵袭和转移活性。
Tumour Biol. 2016 Oct;37(10):13843-13853. doi: 10.1007/s13277-016-5262-0. Epub 2016 Aug 2.
3
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.肝细胞癌中的循环肿瘤细胞:病例与对照的检测、计数及二代测序的初步研究
BMC Cancer. 2015 Mar 31;15:206. doi: 10.1186/s12885-015-1195-z.
4
Extracellular metabolic energetics can promote cancer progression.细胞外代谢能量学可促进癌症进展。
Cell. 2015 Jan 29;160(3):393-406. doi: 10.1016/j.cell.2014.12.018. Epub 2015 Jan 15.
5
Osteopontin shapes immunosuppression in the metastatic niche.骨桥蛋白塑造转移病灶中的免疫抑制。
Cancer Res. 2014 Sep 1;74(17):4706-19. doi: 10.1158/0008-5472.CAN-13-3334. Epub 2014 Jul 17.
6
Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions.检测胰腺囊性病变患者循环胰腺上皮细胞。
Gastroenterology. 2014 Mar;146(3):647-51. doi: 10.1053/j.gastro.2013.12.007. Epub 2013 Dec 13.
7
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.基于惯性聚焦的肿瘤相关抗原依赖和非依赖的稀有循环肿瘤细胞分选。
Sci Transl Med. 2013 Apr 3;5(179):179ra47. doi: 10.1126/scitranslmed.3005616.
8
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.循环干细胞样上皮细胞黏附分子阳性肿瘤细胞预示肝癌根治性切除术后不良预后。
Hepatology. 2013 Apr;57(4):1458-68. doi: 10.1002/hep.26151. Epub 2013 Mar 4.
9
Circulating tumour cells in non-metastatic breast cancer: a prospective study.非转移性乳腺癌中的循环肿瘤细胞:一项前瞻性研究。
Lancet Oncol. 2012 Jul;13(7):688-95. doi: 10.1016/S1470-2045(12)70209-7. Epub 2012 Jun 6.
10
Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer.从局限性和转移性前列腺癌患者中分离和鉴定循环肿瘤细胞。
Sci Transl Med. 2010 Mar 31;2(25):25ra23. doi: 10.1126/scitranslmed.3000403.